| Vitamin D5 | |
|---|---|
 |
|
| IUPAC name |
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,4S)-4-ethyl-1,5-dimethylhexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-1-cyclohexanol
|
| Identifiers | |
| CAS number | 71761-06-3 |
| PubChem | 9547700 |
| SMILES |
CCC(CCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C)C(C)C
|
| Properties | |
| Molecular formula | C29H48O |
| Molar mass | 412.69082 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
Vitamin D5 is a form of vitamin D.
Analogues have been proposed for use as antitumor agents.[1][2][3]
See also
References
- ^ Mehta RG, Moriarty RM, Mehta RR, et al. (February 1997). "Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5". J. Natl. Cancer Inst. 89 (3): 212–8. PMID 9017001. http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=9017001.
- ^ Murillo G, Mehta RG (October 2005). "Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5". J. Steroid Biochem. Mol. Biol. 97 (1-2): 129–36. doi:. PMID 16051482. http://linkinghub.elsevier.com/retrieve/pii/S0960-0760(05)00230-X.
- ^ Mehta RG (October 2004). "Stage-specific inhibition of mammary carcinogenesis by 1alpha-hydroxyvitamin D5". Eur. J. Cancer 40 (15): 2331–7. doi:. PMID 15454260. http://linkinghub.elsevier.com/retrieve/pii/S0959-8049(04)00517-9.
|
|||||||||||||||||||||||||||
 |
This chemistry article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
